HRT Financial’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $919K | Buy |
182,529
+166,946
| +1,071% | +$841K | ﹤0.01% | 1101 |
|
|
2025
Q1 | $100K | Sell |
15,583
-68,466
| -81% | -$439K | ﹤0.01% | 1918 |
|
|
2024
Q4 | $616K | Buy |
84,049
+35,027
| +71% | +$257K | ﹤0.01% | 1171 |
|
|
2024
Q3 | $367K | Buy |
49,022
+13,716
| +39% | +$103K | ﹤0.01% | 1584 |
|
|
2024
Q2 | $314K | Buy |
+35,306
| New | +$314K | ﹤0.01% | 1347 |
|
|
2024
Q1 | – | Sell |
-61,095
| Closed | -$614K | – | 2969 |
|
|
2023
Q4 | $614K | Buy |
+61,095
| New | +$614K | ﹤0.01% | 1160 |
|
|
2023
Q2 | – | Sell |
-118,011
| Closed | -$2.75M | – | 3120 |
|
|
2023
Q1 | $2.75M | Buy |
+118,011
| New | +$2.75M | 0.03% | 436 |
|
|
2022
Q2 | – | Sell |
-25,254
| Closed | -$649K | – | 3575 |
|
|
2022
Q1 | $649K | Buy |
+25,254
| New | +$649K | ﹤0.01% | 1295 |
|
|
2021
Q3 | – | Sell |
-20,558
| Closed | -$971K | – | 3545 |
|
|
2021
Q2 | $971K | Sell |
20,558
-33,080
| -62% | -$1.56M | 0.01% | 1105 |
|
|
2021
Q1 | $2.75M | Buy |
+53,638
| New | +$2.75M | 0.03% | 396 |
|